Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

Peré Domingo(Hospital de Sant Pau), Estebán Martínez(Instituto de Salud Carlos III), Vicente Estrada(Instituto de Salud Carlos III), Francesc Villaroya, José López‐Aldeguer(Hospital de Basurto)

PubMed

August 7, 2012

Cited by 64

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19

|JAMA|2021|728

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

|New England Journal of Medicine|2023|476

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

|The Lancet|2006|343